Medtronic, Inc.
FDA Approves New Medtronic Left Heart Lead for Cardiac Resynchronization Therapy Devices
Published in Medical Letter on the CDC and FDA, May 24th, 2009
Medtronic, Inc. (NYSE: MDT) announced U.S. Food and Drug Administration (FDA) approval and availability of the Attain AbilityŽ left-heart lead (Model 4196) for use with cardiac resynchronization therapy (CRT) devices for heart failure patients. Attain Ability has the thinnest lead body of any left-heart lead currently available, providing physicians with a tool to deliver therapy directly to hard-to-reach areas of the heart. Attain Ability incorporates insulation material developed by NASA Langley Research Center that was previously evaluated for space applications, high-performance engines and harsh environments. This application marks the first time a NASA-developed material has been...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Federation of American Societies for Experimental Biology
New editorial in the FASEB Journal raises concerns over dietary supplements - University of California - Los Angeles
Popular diabetes treatment could trigger pancreatitis, pancreatic cancer - University of Montreal
Treatment for extreme nausea, vomiting during pregnancy - Acorda Therapeutics, Inc.
Acorda Therapeutics Announces FDA Acceptance of Fampridine-SR New Drug Application for Filing - Angiology
Research on angiology detailed by scientists at Georgetown University - Cancer
Research results from Cornell University update knowledge of cancer - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
